American Society of Clinical Oncology-Recommended Surveillance and Physician Specialty Among Long-Term Breast Cancer Survivors

被引:23
作者
Hollowell, Kerry [1 ]
Olmsted, Courtney L. [1 ]
Richardson, Anne S. [1 ]
Pittman, Keith [1 ]
Bellin, Lisa [1 ]
Tafra, Lorraine [2 ]
Verbanac, Kathryn M. [1 ]
机构
[1] E Carolina Univ, Dept Surg, Brody Sch Med, Greenville, NC 27858 USA
[2] Anne Arundel Med Ctr, Breast Ctr, Annapolis, MD USA
关键词
breast cancer surveillance; follow-up guidelines; surveillance mammography; American Society of Clinical Oncology (ASCO); breast cancer guidelines; follow-up breast cancer; long-term surveillance; primary care physician; FOLLOW-UP; CURATIVE TREATMENT; FAMILY PHYSICIAN; UNITED-STATES; PRIMARY-CARE; MAMMOGRAPHY; TRIAL; OSTEOPOROSIS; GUIDELINES; DIAGNOSIS;
D O I
10.1002/cncr.25038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: It is unclear whether it is appropriate to transfer the follow-up care of breast cancer (BrCa) survivors from cancer specialists to primary care physicians (PCPs). This contemporary study compared physician specialty and documented the long-term surveillance of survivors who underwent surgery at an American academic center. METHODS: Women in this institutional review board-approved study underwent breast surgery between 1996 and 2006. Data were collected for 270 patients with stage I to III BrCa (mean follow-up, 6 years). Charts were reviewed based on American Society of Clinical Oncology (ASCO) guidelines for recommended surveillance frequency and care. RESULTS: The majority of patients (90%; n = 242) were followed by specialists with 10% (n = 28) followed by PCPs. Patients with advanced disease and a greater risk of disease recurrence more often received specialist care. Patients followed by specialists were more often seen at ASCO-recommended intervals (eg, 89% vs 69% of patients followed by a PCP at follow-up Year 6; P < .01); however, many patients were followed inconsistently. Breast disease was often not the focus of PCP visits or mentioned in clinic notes (18% patients). Women seen by specialists were more likely to have documented clinical examinations of the breast (93% vs 44% at Year 6), axilla (94% vs 52%), or annual mammograms (74% vs 48%; P = .001-.02). CONCLUSIONS: Consistent compliance with surveillance guidelines and chart documentation needs improvement among all providers; however, specialists more consistently met ASCO guidelines. If transfer of care to a PCP occurs, it should be formalized and include follow-up recommendations and defined physician responsibilities. Providers and patients should be educated regarding surveillance care and current guidelines incorporated into standard clinical practice. Cancer 2010;116:2090-8. (C) 2070 American Cancer Society
引用
收藏
页码:2090 / 2098
页数:9
相关论文
共 38 条
[21]   Improving the quality and efficiency of follow-up after curative treatment for breast cancer - rationale and study design of the MaCare trial [J].
Kimman, Merel L. ;
Voogd, Adri C. ;
Dirksen, Carmen D. ;
Falger, Paul ;
Hupperets, Pierre ;
Keymeulen, Kristien ;
Hebly, Marlene ;
Dehing, Cary ;
Lambin, Philippe ;
Boersma, Liesbeth J. .
BMC CANCER, 2007, 7 (1)
[22]   Reduced mortality rate associated with annual mammograms after breast cancer therapy [J].
Lash, TL ;
Fox, MP ;
Silliman, RA .
BREAST JOURNAL, 2006, 12 (01) :2-6
[23]   Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment [J].
Mandelblatt, JS ;
Lawrence, WF ;
Cullen, J ;
Stanton, AL ;
Krupnick, JL ;
Kwan, L ;
Ganz, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :77-84
[24]   Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature [J].
Montgomery, D. A. ;
Krupa, K. ;
Cooke, T. G. .
BRITISH JOURNAL OF CANCER, 2007, 97 (12) :1632-1641
[25]  
*NAT COMPR CANC NE, 2006, BREAST CANC SCREEN D
[26]   Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
Pestalozzil, B. ;
Castiglione, M. .
ANNALS OF ONCOLOGY, 2008, 19 :7-10
[27]   A retrospective study of first indicators of breast cancer recurrence [J].
Pivot, X ;
Asmar, L ;
Hortobagyi, GN ;
Theriault, R ;
Pastorini, F ;
Buzdar, A .
ONCOLOGY, 2000, 58 (03) :185-190
[28]   Prognostic Implications of Isolated Tumor Cells and Micrometastases in Sentinel Nodes of Patients with Invasive Breast Cancer: 10-Year Analysis of Patients Enrolled in the Prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study [J].
Reed, Jennifer ;
Rosman, Martin ;
Verbanac, Kathryn M. ;
Mannie, Ann ;
Cheng, Zandra ;
Tafra, Lorraine .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (03) :333-340
[29]   Follow-up in women with breast cancer: the patients' perspective [J].
Renton, JP ;
Twelves, CJ ;
Yuille, FAP .
BREAST, 2002, 11 (03) :257-261
[30]  
Ruffin M T, 2000, J Am Board Fam Pract, V13, P1